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Problem statement
• Anthrax outbreaks in livestock occur in all regions 
in Ethiopia and has been mentioned as a major 
constraint for livestock production due to its high 
mortality rate.
• Livestock can be vaccinated, but vaccines are not 
always available when needed.
• Anthrax spores can survive in the environment 
for many years.
• People handling animals or animal products can 
be exposed and get cutaneous, inhalation or 
gastrointestinal anthrax. In the livestock 
production setting, cutaneous anthrax is the 
most common.
• If untreated, anthrax can be fatal also in people.
Understand, prevent and control Anthrax
Key messages and solutions 
• Through focus group discussions (FGDs) 
investigate the real extend of the problem and 
clarify perceptions about anthrax in the 
communities.  
• Conduct participatory disease search to identify 
high risk areas around sites and promote 
prevention by vaccination of livestock.
• Improve knowledge at community level (men and 
women) through trainings on the cause, 
transmission and control options of anthrax in 
livestock and people
• Promote reporting of suspected cases to 
investigate outbreaks and to implement control 
measures, such as proper disposal of carcasses, 
vaccination of susceptible animals and marking of 
sites potentially contaminated with anthrax 
spores. 
Benefits
• Improved awareness and understanding in the 
community about the disease cause, transmission 
and control
• Improved handling of suspicious carcasses
• Reduced risk of exposure to anthrax
• Reduced mortality in small ruminants and other 
livestock
The bacteria Bacillus Anthracis 
produce dormant spores that 
can live in the environment for a 
long time
When spores get into the body of an 
animal or person, they can be activated 
and turn into active growing cells
Active bacteria multiply, 
spread out in the body 
and produce toxins that 
cause severe illness and 
death
Adapted from www.cdc.gov/anthrax/basics/
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Resource requirements (low to high)
Land
Water
Labour
Cash
Access to inputs
Knowledge and skills
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Evidence
• During FGDs in project sites, anthrax was 
ranked among the top diseases by 23 FGDs 
in Amhara, Tigray and SNNP (25% of FGDs). 
Furthermore in Amhara, participants of 
some FGDs had sign of cutaneous Anthrax. 
• Studies also found that awareness of 
zoonotic diseases was very low with only 
46% of respondents being able to name a 
zoonosis. Of these respondents, 52.3% 
mentioned anthrax when asked for an 
example, and most of them stated 
consumption of raw meat from infected 
animals as the main source of infection.
• Even though awareness of anthrax is higher 
compared to other zoonoses, there is an 
obvious need to increase awareness and 
build capacity to deal with outbreaks.
Impact areas (low to high)
Food security
Human nutrition
Employment and livelihoods
Natural resources base
Gender empowerment
Market linkages
Suitability
• This intervention makes sense in sites where 
anthrax has occurred in recent years. 
• The intervention ideally is combined with 
other health and gender interventions. 
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